FDA Inspection 1025392 — Blood Bank of Delmarva, A Division of New York Blood Center, Inc.
The FDA completed an inspection of Blood Bank of Delmarva, A Division of New York Blood Center, Inc. on August 28, 2017 in Hyattsville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hyattsville, MD (United States)